Cargando…

Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies

OBJECTIVE: After an initially successful islet cell transplantation, a number of patients return to C-peptide negativity, and therefore immunosuppressive therapy is discontinued. Some are then found to have developed Graves disease. We examined the risk of Graves disease after immunosuppression. RES...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gillard, Pieter, Huurman, Volkert, Van der Auwera, Bart, Decallonne, Brigitte, Poppe, Kris, Roep, Bart O., Gorus, Frans, Mathieu, Chantal, Pipeleers, Daniel, Keymeulen, Bart
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752930/ https://www.ncbi.nlm.nih.gov/pubmed/19549735 http://dx.doi.org/10.2337/dc08-2339

Ejemplares similares

Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients
por: Hilbrands, Robert, et al.
Publicado: (2009)

Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation
por: Huurman, Volkert A. L., et al.
Publicado: (2008)

Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes
por: van der Torren, Cornelis R., et al.
Publicado: (2016)

CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients
por: Vandewalle, Julie, et al.
Publicado: (2023)

Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens
por: Smeets, Silke, et al.
Publicado: (2021)

The Influence of Prior Hyperthyroidism on Euthyroid Graves' Ophthalmopathy
por: Termote, Karolien, et al.
Publicado: (2014)

Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relatives
por: Vandewalle, Julie, et al.
Publicado: (2021)

Utility of Islet Cell Preparations From Donor Pancreases After Euthanasia
por: De Paep, Diedert L., et al.
Publicado: (2022)

The MicroRNA Landscape of Acute Beta Cell Destruction in Type 1 Diabetic Recipients of Intraportal Islet Grafts
por: Martens, Geert A., et al.
Publicado: (2021)

TPO antibody status prior to first radioactive iodine therapy as a predictive parameter for hypothyroidism in Graves’ disease
por: Verdickt, Sébastien, et al.
Publicado: (2022)

Islet stress, degradation and autoimmunity
por: Thomaidou, Sofia, et al.
Publicado: (2018)

Islet-Resident Dendritic Cells and Macrophages in Type 1 Diabetes: In Search of Bigfoot’s Print
por: Zirpel, Henner, et al.
Publicado: (2021)

Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients
por: Gillard, Pieter, et al.
Publicado: (2013)

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes
por: Keymeulen, Bart, et al.
Publicado: (2020)

Current Advances and Travails in Islet Transplantation
por: Harlan, David M., et al.
Publicado: (2009)

Potential of Protein Phosphatase Inhibitor 1 As Biomarker of Pancreatic β-Cell Injury In Vitro and In Vivo
por: Jiang, Lei, et al.
Publicado: (2013)

Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio
por: Van Dalem, Annelien, et al.
Publicado: (2016)

Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio
por: Van Dalem, Annelien, et al.
Publicado: (2017)

OR03-6 Further Clinical Evaluation of Stem Cell-Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide with Improvements in Glycemic Control Parameters in Multiple Patients with Type 1 Diabetes and Hypoglycemia Unawareness
por: Bellin, Melena, et al.
Publicado: (2022)

Simultaneous Detection of Circulating Autoreactive CD8(+) T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers
por: Velthuis, Jurjen H., et al.
Publicado: (2010)

Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review
por: de Filette, Jeroen M K, et al.
Publicado: (2019)

The importance of an individual approach to Graves’ hyperthyroidism
por: Bednarczuk, Tomasz
Publicado: (2015)

Alternating hyperthyroidism and hypothyroidism in Graves’ disease
por: Wong, Mimi, et al.
Publicado: (2018)

New Therapeutic Horizons for Graves’ Hyperthyroidism
por: Lane, Laura C, et al.
Publicado: (2020)

R-CHOP-Associated Graves' Hyperthyroidism
por: Mora, Natalie, et al.
Publicado: (2019)

Toward Ultimate Care for Graves’ Hyperthyroidism
por: Azizi, Fereidoun, et al.
Publicado: (2019)

The Grave Hematologic and Hepatic Effects of Hyperthyroidism
por: Ahmad, Sara Miriam, et al.
Publicado: (2021)

Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes
por: Demeester, Simke, et al.
Publicado: (2015)

Lnk Inhibits Tpo–mpl Signaling and Tpo-mediated Megakaryocytopoiesis
por: Tong, Wei, et al.
Publicado: (2004)

Contribution of Antibodies Against IA-2β and Zinc Transporter 8 to Classification of Diabetes Diagnosed Under 40 Years of Age
por: Vermeulen, Ilse, et al.
Publicado: (2011)

Pretransplant Immune Parameters Associate With Islet Allograft Outcome: Implications for Transplant Strategy?
por: Kenyon, Norma S., et al.
Publicado: (2009)

Comprehensive analysis of gene expression of isolated pancreatic islets during pretransplant culture
por: Haga, Junichiro, et al.
Publicado: (2021)

Current and emerging treatment options for Graves’ hyperthyroidism
por: Abraham, Prakash, et al.
Publicado: (2010)

Hyperthyroidism and Graves’ disease: Is an ultrasound examination needed?
por: Varadhan, Lakshminarayanan, et al.
Publicado: (2016)

Graves’ hyperthyroidism in pregnancy: a clinical review
por: Nguyen, Caroline T., et al.
Publicado: (2018)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

Syntaxin 4 Expression in Pancreatic β-Cells Promotes Islet Function and Protects Functional β-Cell Mass
por: Oh, Eunjin, et al.
Publicado: (2018)

Pancytopenia with cellular bone marrow related to Graves’ hyperthyroidism
por: Raina, Sujeet, et al.
Publicado: (2012)

Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
por: Nwatsock, J. F., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vas3nlappk40pudb8ogtnd09jh